A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)

NCT00856635 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Glatiramer Acetate
DRUG: placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.